Clinical Trial Update: Economic Analyses of the REDUCE Trial

View source ↗

Summary

This document reports economic analyses based on the REDUCE trial, evaluating the cost-effectiveness and economic impact of dutasteride in men at risk for prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate, Benign Prostatic Hyperplasia | Status: COMPLETED